ouabain has been researched along with g(m1) ganglioside in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bharucha, VA; Karpiak, SE; Mahadik, SP; Ortiz, A; Stadlin, A | 1 |
Bonvento, G; Lazzaro, A; Lipartiti, M; Mazzari, S; Zanoni, R | 1 |
Canella, R; Gorio, A; Norido, F; Zanoni, R | 1 |
3 other study(ies) available for ouabain and g(m1) ganglioside
Article | Year |
---|---|
Loss and recovery of activities of alpha+ and alpha isozymes of (Na(+) + K+)-ATPase in cortical focal ischemia: GM1 ganglioside protects plasma membrane structure and function.
Topics: Animals; Autoradiography; Brain Ischemia; Cell Membrane; Cerebral Cortex; G(M1) Ganglioside; Isoenzymes; Male; Ouabain; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase | 1992 |
Effects of monosialoganglioside GM1 in experimental models of ischemic brain damage.
Topics: Animals; Brain; Brain Damage, Chronic; Brain Ischemia; Choline O-Acetyltransferase; G(M1) Ganglioside; Injections, Intraventricular; N-Methylaspartate; Organ Size; Ouabain; Rats | 1991 |
Monosialoganglioside (GM1) treatment of ouabain-induced retinopathy in the rabbit.
Topics: Animals; Electroretinography; Evoked Potentials, Visual; G(M1) Ganglioside; Gangliosides; Injections, Intravenous; Male; Ouabain; Rabbits; Retinal Degeneration; Retinal Diseases; Time Factors | 1983 |